Intersect ENT Receives $1,018,585 Series C Financing Round

  • Feed Type
  • Date
    9/2/2011
  • Company Name
    Intersect ENT
  • Mailing Address
    1049 Elwell Court Palo Alto, CA 94303
  • Company Description
    Intersect ENT Inc. (formerly Sinexus) is a medical device company pioneering novel therapies for Ear, Nose & Throat surgeons to utilize in providing improved treatment for their patients.
  • Website
    http://www.intersectent.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $1,018,585
  • Transaction Round
    Series C
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing-amended.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.